Analyst picks & changes

Genetics Institute Inc.

(GENIZ)

Oppenheimer & Co. analyst Matthew Geller repeated a "market perform" rating on the Cambridge, Mass., company following the announcement of Phase II results showing that

Neumega

Interleukin-11 was effective in restoring platelets following chemotherapy (see Clinical

Read the full 417 word article

How to gain access

Continue reading with a
two-week free trial.